Last year we included a section in the BioWorld Biotechnology StateOf The Industry Report on CEO compensation that was so popular,we expanded it to a stand-alone report called BioWorld CEOCompensation Report.

It provides a detailed analysis of CEO compensation at public biotechcompanies, a significant gauge of this difficult-to-assess industry.

What we found, via data directly from proxy statements, is thatbiotechnology companies' CEOs earn an average of $260,261. But,surprisingly, those executives who receive the highest annualcompensation are not necessarily from the largest companies. The 50-page report analyzes CEO compensation in dozens of ways: bydisease or technology focus, market capitalization, state and more.

(c) 1997 American Health Consultants. All rights reserved.